Eagle Pharmaceuticals
EGRX
#10472
Rank
S$4.15 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-84.28%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: S$4.15 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of S$4.15 Million. This makes Eagle Pharmaceuticals the world's 10472th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026S$4.15 M-44.49%
2025S$7.48 M-22.72%
2024S$9.68 M-89.2%
2023S$89.7 M-82.41%
2022S$0.51 B-42.63%
2021S$0.88 B10.74%
2020S$0.80 B-27.29%
2019S$1.10 B44.16%
2018S$0.76 B-28.17%
2017S$1.06 B-40.01%
2016S$1.77 B-9.39%
2015S$1.96 B582.2%
2014S$0.28 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
S$4.15 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$745.00 B 17,927,316.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$408.24 B 9,823,663.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$1.224 T 29,475,268.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$260.93 B 6,278,994.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$157.32 B 3,785,721.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$151.25 B 3,639,674.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$49.82 B 1,198,922.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel